South African Government


The National Institute for Communicable Diseases (NICD) says the country is experiencing a sustained downward trend in new COVID-19 infections.

On Sunday, the country recorded 2 281 new laboratory confirmed cases, with 58 new COVID-19 related deaths.

There were 79 new hospitalisations as a result of the disease.

“The total number of cases… is lower than yesterday and lower than the average number of new cases per day over the seven preceding days. The seven-day moving average daily number of cases has decreased,” the NICD said.

The institute said the new cases represent a positivity rate of 7.4%.

“The majority of new cases… are from KwaZulu-Natal (518), followed by Western Cape (390). Northern Cape (309) and Eastern Cape (321), Gauteng Province accounted for (235), Free State accounted for 212; Mpumalanga accounted for 148; North West accounted for 124 and Limpopo accounted for 24 of… new cases,” the institute said.

The total number of laboratory confirmed COVID-19 cases now stand at 2, 882, 630, with 86, 174 people succumbing to illnesses related to the disease.

At least 17, 598 vaccines were administered on Sunday, bringing the total number of vaccines administered to just under 16 million.

Fully vaccinated individuals now account for at least 7.9 million people in the country.

Distributed by APO Group on behalf of South African Government.

Send us your press releases to pressrelease.zawya@refinitiv.com


© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.